Provided by Tiger Fintech (Singapore) Pte. Ltd.

Harmony Biosciences Holdings, Inc.

31.93
+0.04000.13%
Post-market: 31.930.00000.00%16:10 EDT
Volume:649.52K
Turnover:20.66M
Market Cap:1.83B
PE:12.18
High:32.45
Open:32.14
Low:31.40
Close:31.89
Loading ...

BRIEF-Harmony Biosciences Q1 Net Income USD 45.56 Million

Reuters
·
06 May

Harmony Biosciences Q1 Operating Income USD 56.245 Million

THOMSON REUTERS
·
06 May

Harmony Biosciences Q1 Net Income USD 45.56 Million

THOMSON REUTERS
·
06 May

Harmony Biosciences: Reaffirms 2025 Revenue Guidance

THOMSON REUTERS
·
06 May

Harmony Biosciences: Expect FY 2025 Net Product Revenue of $820 Mln to $860 Mln

THOMSON REUTERS
·
06 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
06 May

Harmony Biosciences Holdings Inc expected to post earnings of 59 cents a share - Earnings Preview

Reuters
·
02 May

Will Cue Biopharma, Inc. (CUE) Report Negative Q1 Earnings? What You Should Know

Zacks
·
01 May

Harmony Biosciences to Report First Quarter 2025 Financial Results on May 6, 2025

Business Wire
·
29 Apr

Harmony Biosciences Is Maintained at Buy by UBS

Dow Jones
·
29 Apr

UBS Adjusts Price Target on Harmony Biosciences to $48 From $55, Maintains Buy Rating

MT Newswires Live
·
28 Apr

Harmony Biosciences price target lowered to $48 from $55 at UBS

TIPRANKS
·
28 Apr

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Harmony Biosciences Holdings (HRMY), Apellis Pharmaceuticals (APLS) and Eton Pharmaceuticals (ETON)

TIPRANKS
·
28 Apr

BofA Cuts Price Target on Harmony Biosciences to $32 From $33

MT Newswires Live
·
21 Apr

JAZZ vs. HRMY: Which Neuroscience Drugmaker Is the Stronger Play?

Zacks
·
21 Apr

Positive Outlook for Harmony Biosciences’ ZYN002: Strong Phase 2 Data and Global Rights Support Buy Rating

TIPRANKS
·
09 Apr

Harmony Biosciences Price Target Maintained With a $50.00/Share by Needham

Dow Jones
·
08 Apr

Positive Outlook for Harmony Biosciences Holdings Based on Promising ZYN-002 Study Results

TIPRANKS
·
08 Apr

Harmony Biosciences Presents Promising Open-Label Extension Data of ZYN002 in Fragile X Syndrome

Business Wire
·
08 Apr

Harmony Biosciences Holdings, Inc. (HRMY): A Bull Case Theory

Insider Monkey
·
04 Apr